May 29, 2003 

is a production of
ScienCentral, Inc.
Making Sense of Science

Also of Interest
Anthrax Genome (video)

Drugs from the Deep (video)

Alzheimer’s Scans (video)

Protein Machine (video)

DNA’s Dark Lady (video)

Brain Viagra - Part 1 (video)

Brain Viagra - Part 2 (video)

Placebo Effect (video)

Gene Taxpayers (video)

Good Fish, Bad Fish (video)

Slowing Alzheimer’s (video)

Birth Alert (video)

Fat Attackers (video)

Older Women and Exercise (video)

Gulf War Syndrome Gene (video)

NOVA News Minutes
Visit the NOVA News Minutes archive.
ScienCentral News and Nature
Nature genome promo logo
Don’t miss Enter the Genome
our collaboration with Nature.
Best of the Web!
Popular Science Best of the Web 2000
Selected one of Popular Science’s 50 Best of the Web.
Get Email Updates
Write to us and we will send you an email when a new feature appears on the site.
Cancer-proof Mice (video)
May 06, 2003

Can't see the movie above??
download realplayer logo
You can choose to either view it with a RealPlayer by clicking here. Or get the free QuickTime player to view the higher-quality video above.

Interviewee: Zheng Cui, Wake Forest University Baptist Medical Center.

Video is 1 min 36 sec long. Please be patient while it loads enough to start playing.

Produced by Joyce Gramza

Copyright © ScienCentral, Inc., with additional footage from Wake Forest University.

Also on ScienCentral News

Drugs from the Deep - Ocean scientists have found an unlikely new source of many drugs—deep ocean mud. (4/29/03)

Models of Health - Geneticists are using new high-tech tools to study animals that live long lives, hoping to identify genes that may cause aging. (2/4/03)

Elsewhere on the web

The Mouse in Science - Cancer Research

American Cancer Society

A patient has end-stage cancer and suddenly, inexplicably, his cancer disappears. At last, scientists have proof of how that can happen.

As this ScienCentral News video reports, they’ve accidentally discovered a cancer-proof mouse.

Mighty Mouse

We have all heard stories of cancer patients who've experienced miraculous cures. We call it a miracle, but cancer researchers call it “spontaneous regression.” These cases are rare, and almost impossible to follow up on. But researchers at Wake Forest University now have a colony of mice whose immune systems destroy cancer cells.

As they write in the May 27, 2003 issue of Proceedings of the National Academy of Sciences, a team led by Zheng Cui, associate professor of pathology at the Wake Forest University Baptist Medical Center, discovered a mouse that just wouldn’t get cancer, despite being injected repeatedly with aggressive cancer cells.

“This mouse can withstand the challenge of an almost unlimited number of cancer cells,” says Cui. “We tried 500,000, we tried 5 million, we tried 50 million, we tried 500 million. We even tried several billion cancer cells injected into this mouse. Surprisingly to all of us here, none of these injections caused this mouse to develop cancer. But all the other normal mice will develop cancer even with a very small number of cancer cells injected.”

Also amazing, says Cui, is that normal cells are unharmed—the mice stay perfectly healthy. “If you consider the current therapy in humans, we have to endure very profound side effects to kill cancer cells,” says Cui. “However, in these mice, what was amazing to us is that they don't seem to have a side effect. They can selectively kill cancer cells.”

Cui believes the mouse must have had a mutation in a single gene. It transmitted the trait to half its offspring, displaying "a perfect Mendelian single dominant gene pattern,” says Cui. The scientists have since bred a colony of some 700 of the mice and are working to identify the gene and the mutation. "If we can find out…how this mutation can function to activate immune cells, to allow immune cells to recognize these cancer cells and be able to destroy them," he says, "hopefully we can learn from this mouse study and then design similar strategies in human therapies.”

They do have some clues. The immune system cells that recognize and kill the cancer cells are part of the innate immune system. The researchers also found that if they collected these immune cells from a cancer-resistant mouse and injected it into normal mice "that were otherwise very sensitive to the cancer cells, then these normal mice would acquire similar ability to eradicate these cancer cells," says Cui.

The cancer resistance is also age-dependent. The younger the mice are when they’re exposed to the cancer, the more quickly their immune systems react to kill the cancer cells. Once they have resisted cancer, they are protected for life. “However, when you inject the mouse very late with cancer cells, let's say at one year of age, their offspring can be cancer resistant, but these parents will not, because somehow old age will prevent the expression of these resistant mechanisms,” Cui says. Because cancer is generally a disease of aging, this suggests that there may be a way to "vaccinate" the immune system against cancer.

New Therapies

The discovery of the cancer-resistant mouse doesn't mean any change in cancer treatments for humans yet. “This is a study just in mice now, although we are quite excited," Cui says. "We hope that we can work hard enough and be smart enough to figure out this mechanism in the shortest possible time."

Cui says possible strategies for human patients might include "using drugs to stimulate similar pathways, or to use gene therapy to simply put the mutated gene or similar genes with similar mutations into the white blood cells or even into bone marrow stem cells that will allow similar cancer-killer cells to be created.”

He hopes the research will reveal how our own immune systems can be mobilized against disease. “I think we can learn a lot through this model about cancer cells and about ourselves. That is, our own bodies have great potential to be used for therapies against disease."

The funders of this research were Wake Forest University, the Charlotte Geyer Foundation, the National Cancer Institute, and the Cancer Research Institute.



by Karen Lurie


About Search Login Help Webmaster
ScienCentral News is a production of ScienCentral, Inc.
in collaboration with the Center for Science and the Media.
248 West 35th St., 17th Fl., NY, NY 10001 USA (212) 244-9577.
The contents of these WWW sites © ScienCentral, 2000-2003. All rights reserved.
The views expressed in this website are not necessarily those of the NSF.
NOVA News Minutes and NOVA are registered trademarks of WGBH Educational Foundation and are being used under license.